- Home
- LESL vs NKTR Comparison
LESL vs NKTR Comparison
Compare LESL & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LESL
- NKTR
- Stock Information
- Founded
- LESL 1963
- NKTR 1990
- Country
- LESL United States
- NKTR United States
- Employees
- LESL N/A
- NKTR N/A
- Industry
- LESL Diversified Commercial Services
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- LESL Miscellaneous
- NKTR Health Care
- Exchange
- LESL Nasdaq
- NKTR Nasdaq
- Market Cap
- LESL 156.0M
- NKTR 160.4M
- IPO Year
- LESL 2020
- NKTR 1994
- Fundamental
- Price
- LESL $0.83
- NKTR $0.74
- Analyst Decision
- LESL Hold
- NKTR Strong Buy
- Analyst Count
- LESL 11
- NKTR 5
- Target Price
- LESL $2.70
- NKTR $5.50
- AVG Volume (30 Days)
- LESL 5.9M
- NKTR 1.4M
- Earning Date
- LESL 05-07-2025
- NKTR 03-12-2025
- Dividend Yield
- LESL N/A
- NKTR N/A
- EPS Growth
- LESL N/A
- NKTR N/A
- EPS
- LESL N/A
- NKTR N/A
- Revenue
- LESL $1,331,389,000.00
- NKTR $98,427,000.00
- Revenue This Year
- LESL $2.85
- NKTR N/A
- Revenue Next Year
- LESL $3.00
- NKTR N/A
- P/E Ratio
- LESL N/A
- NKTR N/A
- Revenue Growth
- LESL N/A
- NKTR 9.21
- 52 Week Low
- LESL $0.75
- NKTR $0.65
- 52 Week High
- LESL $6.64
- NKTR $1.93
- Technical
- Relative Strength Index (RSI)
- LESL 33.55
- NKTR 36.32
- Support Level
- LESL $0.75
- NKTR $0.84
- Resistance Level
- LESL $0.96
- NKTR $0.92
- Average True Range (ATR)
- LESL 0.09
- NKTR 0.08
- MACD
- LESL 0.04
- NKTR -0.01
- Stochastic Oscillator
- LESL 32.39
- NKTR 0.40
About LESL Leslie's Inc.
Leslies Inc is a direct-to-consumer pool and spa care brand offering a comprehensive assortment of products across chemicals, equipment and parts, cleaning and maintenance equipment, and safety, recreational, and fitness-related products. The company offers its products and services for Residential Pool, Residential Spa, Professional Pool, and Commercial Pool consumers. Geographically, it operates only in the United States.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.